Detailed Narrative
Q4 FY26 and Full-Year FY26 Performance Overview
Sharda Cropchem reported its best-ever annual performance in FY26, with revenue growing 22% year-on-year to INR 5,268 crores and PAT surging 124% year-on-year to INR 681 crores. Q4 FY26 also demonstrated strong growth, with revenues increasing by 13% to INR 2,065 crores and PAT by 57% to INR 319 crores. EBITDA for Q4 FY26 grew 75% to INR 513 crores, achieving a margin of 24.8%, while full-year EBITDA reached INR 1,040 crores with a 19.7% margin.
Revenue Growth Drivers and Margins
The 13% revenue growth in Q4 FY26 was primarily driven by a 4.3% volume growth and a significant 11.7% positive impact from FOREX, partially offset by a -3.0% impact from price and product mix. For the full year FY26, volume growth was 13.4%, FX impact🌐 was 10.3%, and price/product mix was -1.8%. Gross margins expanded by 750 basis points to 37.3% in Q4 FY26 and by 600 basis points to 35.9% for the full year, attributed to the company's ability to pass on raw material price increases due to limited competition in its registration-based business model.
Segmental Performance and Geographic Contribution
The agrochemical business grew by 14% year-on-year in Q4 FY26 to INR 1,927 crores and by 25% for the full year to INR 4,717 crores. The non-agrochemical segment showed marginal growth of 0.3% in Q4 FY26, reaching INR 138 crores, and 1% growth for the full year, totaling INR 551 crores. Volume growth was particularly strong in Europe and LATAM, while the NAFTA agrochemical segment experienced a 6% revenue degrowth in Q4 FY26 due to weather and economic conditions.
Product Registrations and Pipeline
As of March 31, 2026, Sharda Cropchem held 3,011 product registrations globally, with an additional 1,004 applications in the pipeline. Management emphasized that while the registration process is complex, time-consuming, and subject to bureaucratic delays, the company is optimistic about securing a good number of new registrations in FY27. They clarified that business growth is not solely dependent on new registrations but also on market share expansion and sustained demand for existing products.
Capital Structure and Shareholder Returns
The company maintains a debt-free status, holding cash and bank liquid investments of INR 702 crores as of March 31, 2026. CAPEX for FY26 amounted to INR 505 crores. The Board recommended a final dividend of INR 9 per equity share, which, combined with the interim dividend of INR 6 per equity share paid in December 2025, brings the total dividend for FY26 to INR 15 per share.
Outlook and Geopolitical Resilience
For FY27, Sharda Cropchem expects revenue to grow by 10% to 15%, with gross margins maintained around 35% plus or minus a few percentage points, and EBITDA margins targeted between 18% to 20%. The company demonstrated resilience against geopolitical events, confirming no major challenges in sourcing from China or significant logistics disruptions due to the Middle East war. Furthermore, the company continues to supply goods to Ukraine, receiving orders and payments on time, highlighting the essential nature of agrochemicals.